Aspirin- and butalbital- and caffeine- and codeine-containing product in oral dose form
RxNorm 1154056
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1154056 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Aspirin- and butalbital- and caffeine- and codeine-containing product in oral dose form.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDGPrescribable
Semantic Clinical Dose Form Group (SCDG):
Aspirin / butalbital / caffeine / codeine Oral Product
(Atom ID: 12287804)
PTPrescribable
Designated preferred name (PT):
Aspirin- and butalbital- and caffeine- and codeine-containing product in oral dose form
(Atom ID: 10797164)
FNPrescribable